Gezim Bala1,2, Henri Baudhuin1, Isabel Remory1,3, Kris Gillis1,2, Pieterjan Debie1, Ahmet Krasniqi1, Tony Lahoutte1,4, Geert Raes5,6, Nick Devoogdt1, Bernard Cosyns1,2, Sophie Hernot7. 1. In Vivo Cellular and Molecular Imaging (ICMI/BEFY), Vrije Universiteit Brussel, Brussels, Belgium. 2. Centrum voor Hart-en Vaatziekten (CHVZ), UZ Brussel, Brussels, Belgium. 3. Department of Anesthesiology, UZBrussel, Brussels, Belgium. 4. Nuclear Medicine Department, UZ Brussel, Brussels, Belgium. 5. Laboratory of Cellular and Molecular Immunology (CMIM), Vrije Universiteit Brussel, Brussels, Belgium. 6. Myeloid Cell Immunology Lab, VIB Inflammation Research Center, Ghent, Belgium. 7. In Vivo Cellular and Molecular Imaging (ICMI/BEFY), Vrije Universiteit Brussel, Brussels, Belgium. sophie.hernot@gmail.com.
Abstract
PURPOSE: Macrophage accumulation characterizes the development of atherosclerotic plaques, and the presence of certain macrophage subsets might be an indicator of plaque phenotype and (in)stability. The macrophage mannose receptor (MMR) is expressed on alternatively activated macrophages and found at sites of intraplaque hemorrhage and neovascularization. It has been proposed as target to identify vulnerable plaques. Therefore, we aimed to assess the feasibility of using anti-MMR nanobodies (Nbs) as molecular tracers for nuclear imaging in an animal model of atherosclerosis. PROCEDURE: Anti-MMR and control Nb, radiolabeled with Tc-99m, were injected in ApoE-/- and/or C57Bl/6 mice (n = 6). In vivo competition studies involving pre-injection of excess of unlabeled anti-MMR Nb (n = 3) and injection of anti-MMR Nb in MMR-/- mice (n = 3) were performed to demonstrate specificity. At 3 h p.i. radioactive uptake in organs, tissues and aorta segments were evaluated. Autoradiography and immunofluorescence were performed on aortic sections. RESULTS: Significantly higher uptake was observed in all aortic segments of ApoE-/- mice injected with anti-MMR Nb compared to control Nb (1.36 ± 0.67 vs 0.38 ± 0.13 percent of injected dose per gram (%ID/g), p ≤ 0.001). Surprisingly, high aortic uptake was also observed in C57Bl/6 mice (1.50 ± 0.43%ID/g, p ≥ 0.05 compared to ApoE-/-), while aortic uptake was reduced to background levels in the case of competition and in MMR-/- mice (0.46 ± 0.10 and 0.22 ± 0.06%ID/g, respectively; p ≤ 0.001). Therefore, expression of MMR along healthy aortas was suggested. Autoradiography showed no specific radioactive signal within atherosclerotic plaques, but rather localization of the signal along the aorta, correlating with MMR expression in perivascular tissue as demonstrated by immunofluorescence. CONCLUSIONS: No significant uptake of MMR-specific Nb could be observed in atherosclerotic lesions of ApoE-/- mice in this study. A specific perivascular signal causing a non-negligible background level was demonstrated. This observation should be considered when using MMR as a target in molecular imaging of atherosclerosis, as well as use of translational animal models with vulnerable plaques.
PURPOSE: Macrophage accumulation characterizes the development of atherosclerotic plaques, and the presence of certain macrophage subsets might be an indicator of plaque phenotype and (in)stability. The macrophage mannose receptor (MMR) is expressed on alternatively activated macrophages and found at sites of intraplaque hemorrhage and neovascularization. It has been proposed as target to identify vulnerable plaques. Therefore, we aimed to assess the feasibility of using anti-MMR nanobodies (Nbs) as molecular tracers for nuclear imaging in an animal model of atherosclerosis. PROCEDURE: Anti-MMR and control Nb, radiolabeled with Tc-99m, were injected in ApoE-/- and/or C57Bl/6 mice (n = 6). In vivo competition studies involving pre-injection of excess of unlabeled anti-MMR Nb (n = 3) and injection of anti-MMR Nb in MMR-/- mice (n = 3) were performed to demonstrate specificity. At 3 h p.i. radioactive uptake in organs, tissues and aorta segments were evaluated. Autoradiography and immunofluorescence were performed on aortic sections. RESULTS: Significantly higher uptake was observed in all aortic segments of ApoE-/- mice injected with anti-MMR Nb compared to control Nb (1.36 ± 0.67 vs 0.38 ± 0.13 percent of injected dose per gram (%ID/g), p ≤ 0.001). Surprisingly, high aortic uptake was also observed in C57Bl/6 mice (1.50 ± 0.43%ID/g, p ≥ 0.05 compared to ApoE-/-), while aortic uptake was reduced to background levels in the case of competition and in MMR-/- mice (0.46 ± 0.10 and 0.22 ± 0.06%ID/g, respectively; p ≤ 0.001). Therefore, expression of MMR along healthy aortas was suggested. Autoradiography showed no specific radioactive signal within atherosclerotic plaques, but rather localization of the signal along the aorta, correlating with MMR expression in perivascular tissue as demonstrated by immunofluorescence. CONCLUSIONS: No significant uptake of MMR-specific Nb could be observed in atherosclerotic lesions of ApoE-/- mice in this study. A specific perivascular signal causing a non-negligible background level was demonstrated. This observation should be considered when using MMR as a target in molecular imaging of atherosclerosis, as well as use of translational animal models with vulnerable plaques.
Authors: J Lauran Stöger; Marion J J Gijbels; Saskia van der Velden; Marco Manca; Chris M van der Loos; Erik A L Biessen; Mat J A P Daemen; Esther Lutgens; Menno P J de Winther Journal: Atherosclerosis Date: 2012-09-26 Impact factor: 5.162
Authors: J H Lardenoye; D J Delsing; M R de Vries; M M Deckers; H M Princen; L M Havekes; V W van Hinsbergh; J H van Bockel; P H Quax Journal: Circ Res Date: 2000-08-04 Impact factor: 17.367
Authors: Anneleen Blykers; Steve Schoonooghe; Catarina Xavier; Kevin D'hoe; Damya Laoui; Matthias D'Huyvetter; Ilse Vaneycken; Frederik Cleeren; Guy Bormans; Johannes Heemskerk; Geert Raes; Patrick De Baetselier; Tony Lahoutte; Nick Devoogdt; Jo A Van Ginderachter; Vicky Caveliers Journal: J Nucl Med Date: 2015-06-11 Impact factor: 10.057
Authors: Stéphanie Put; Steve Schoonooghe; Nick Devoogdt; Evelien Schurgers; Anneleen Avau; Tania Mitera; Matthias D'Huyvetter; Patrick De Baetselier; Geert Raes; Tony Lahoutte; Patrick Matthys Journal: J Nucl Med Date: 2013-02-27 Impact factor: 10.057
Authors: Gezim Bala; Anneleen Blykers; Catarina Xavier; Benedicte Descamps; Alexis Broisat; Catherine Ghezzi; Daniel Fagret; Guy Van Camp; Vicky Caveliers; Christian Vanhove; Tony Lahoutte; Steven Droogmans; Bernard Cosyns; Nick Devoogdt; Sophie Hernot Journal: Eur Heart J Cardiovasc Imaging Date: 2016-01-22 Impact factor: 6.875
Authors: Max L Senders; Sophie Hernot; Giuseppe Carlucci; Jan C van de Voort; Francois Fay; Claudia Calcagno; Jun Tang; Amr Alaarg; Yiming Zhao; Seigo Ishino; Anna Palmisano; Gilles Boeykens; Anu E Meerwaldt; Brenda L Sanchez-Gaytan; Samantha Baxter; Laura Zendman; Mark E Lobatto; Nicolas A Karakatsanis; Philip M Robson; Alexis Broisat; Geert Raes; Jason S Lewis; Sotirios Tsimikas; Thomas Reiner; Zahi A Fayad; Nick Devoogdt; Willem J M Mulder; Carlos Pérez-Medina Journal: JACC Cardiovasc Imaging Date: 2018-10-17
Authors: Bjoern Traenkle; Philipp D Kaiser; Stefania Pezzana; Jennifer Richardson; Marius Gramlich; Teresa R Wagner; Dominik Seyfried; Melissa Weldle; Stefanie Holz; Yana Parfyonova; Stefan Nueske; Armin M Scholz; Anne Zeck; Meike Jakobi; Nicole Schneiderhan-Marra; Martin Schaller; Andreas Maurer; Cécile Gouttefangeas; Manfred Kneilling; Bernd J Pichler; Dominik Sonanini; Ulrich Rothbauer Journal: Front Immunol Date: 2021-12-09 Impact factor: 7.561